Image

Revascularization for Symptomatic Non-acute Carotid Artery Occlusion

Revascularization for Symptomatic Non-acute Carotid Artery Occlusion

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The short-term and long-term efficacy of recanalization therapy needs to be further confirmed by large-sample prospective studies. The comparison of success rate, complication rate and efficacy among the three recanalization modalities also needs to be further explored. The purpose of this cohort study is to observe the success rate, efficacy and safety of recanalization treatment for non-acute occlusion, and to further compare the advantages and disadvantages of CEA, endovascular intervention and hybrid surgery.

Description

Carotid artery occlusion is one of the primary causes of ischemic stroke. When the occlusion time exceeds 30 days, it is commonlly referred to as chronic carotid artery occlusion (CCAO), and patients with carotid artery occlusion over 24 hours are collectively referred as non-acute occlusion. Symptomatic non-acute occlusion patients with definite hemodynamic hypoperfusion still face a high risk of stroke recurrence under drug treatment, with recurrence rates reported to be between 12.3% and 22.7% within 2 years. Currently, the surgical methods for the treatment of carotid artery occlusion are mainly divided into extracranial-intracranial (EC-IC) bypass and recanalization treatment. Recanalization treatment includes CEA, endovascular intervention and hybrid surgery. While the Carotid Occlusion Surgery Study (COSS) and the recently published Carotid or Middle cerebral artery Occlusion Surgery Study (CMOSS) failed to reveal the significant advantages of EC-IC bypass surgery over medical treatment for patients with symptomatic artery occlusion combined with hemodynamic insufficiency, recanalization treatment has been shown to be a promising treatment modality by case-control studies with small sample size. However, the short-term and long-term efficacy of recanalization therapy needs to be further confirmed by large-sample prospective studies. The comparison of success rate, complication rate and efficacy among the three recanalization modalities also needs to be further explored. In addition, about half of non-acute occlusion patients have cognitive impairment, and the role of cerebral hemodynamics in cognitive impairment is still unclear. Therefore, the purpose of this cohort study is to observe the success rate, efficacy and safety of recanalization treatment for non-acute occlusion, and to further compare the advantages and disadvantages of CEA, endovascular intervention and hybrid surgery.

Eligibility

Inclusion Criteria:

  1. Older than 18 years old;
  2. Sign the informed consent form;
  3. Carotid occlusion at least 24h;
  4. Patients with clinical localization symptoms: ipsilateral hemisphere ischemia symptoms or ipsilateral eye ischemia symptoms or cognition impairment, with or without anterior circulation blood supply area infarction;
  5. DSA confirmed common carotid artery or internal carotid artery (mTICI=0) occlusion;
  6. Perfusion imaging confirms the presence of hypoperfusion in the corresponding area(CBF decrease);
  7. The optimal medical treatment for patients who still have ischemic symptoms;
  8. Routine DWI and ADC sequence examinations are performed before surgery no new infarction;

Exclusion Criteria:

  1. Intracranial arteriovenous malformation or aneurysm;
  2. Unstable angina, myocardial infarction (MI), or congestive heart failure in the last 6 months;
  3. Uncontrolled diabetes mellitus defined as glucose > 300 mg/dL (16.67 mmol/L);
  4. Patient is expected to have the ADP antagonist therapy interruption within 3 months after the procedure;
  5. Pregnant or in the perinatal period;
  6. Severe concomitant disease with poor prognosis (life expectancy < 3 years);
  7. Intolerance or allergies to any of the study medications, such as aspirin or clopidogrel;
  8. Allergy to iodine or radiographic contrast media;
  9. Concomitant vascular conditions precluding endovascular;
  10. Patients with large cerebral infarction within 2 weeks;
  11. History of ipsilateral vocal cord paralysis;
  12. Those with severe skin diseases who are expected to have difficulty healing the incision;
  13. Poor functional status before onset (mRS score 4-5 points).
  14. The area of infarction in the occluded vascular area exceeds half of the vascular supply area;
  15. Already have dementia or psychiatric illness and are unable to complete neurological and cognitive assessments.
  16. Any condition that in the surgeon's judgment suggests the patient an unsuitable surgical candidate.

Study details
    Non-acute Carotid Artery Occlusion

NCT06303414

Xuanwu Hospital, Beijing

19 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.